+321 123 4567
info@test.com
My Account
  1. Home
  2. /
  3. Availability
  4. /
  5. Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered

Making wider use of the world’s most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered

Description

This paper assesses the effectiveness and cost-effectiveness of revaccinating adolescents in a setting with intense transmission—Cape Town, South Africa.
WHO goals and milestones
Availability, Economic impact/cost-effectivenss, Epidemiological impact

Project details

Country
South Africa
Timeline
Target group
adolescents
Vaccine
BCG revax
Type of protection of vaccine
Prevention of infection
Type of research
Modelling
Partners involved
BMGF; Aeras; WHO
Type of project

Resources

Contact

Joeri Buis

KNCV Team

Contact me for more information about this research

Click to copy link of this header Menu

Add A Knowledge Base Question !

You will receive an email when your question will be answered.

+ = Verify Human or Spambot ?